1. Home
  2. LGL vs XGN Comparison

LGL vs XGN Comparison

Compare LGL & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGL Group Inc. (The)

LGL

LGL Group Inc. (The)

N/A

Current Price

$5.69

Market Cap

34.1M

Sector

Technology

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$6.39

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGL
XGN
Founded
1917
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.1M
253.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
LGL
XGN
Price
$5.69
$6.39
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$13.67
AVG Volume (30 Days)
10.5K
246.3K
Earning Date
11-13-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
149.85
N/A
EPS
0.17
N/A
Revenue
$4,107,000.00
$63,599,000.00
Revenue This Year
N/A
$22.15
Revenue Next Year
N/A
$15.26
P/E Ratio
$33.25
N/A
Revenue Growth
N/A
14.08
52 Week Low
$5.45
$2.67
52 Week High
$9.74
$12.23

Technical Indicators

Market Signals
Indicator
LGL
XGN
Relative Strength Index (RSI) 43.10 24.04
Support Level $5.50 $6.37
Resistance Level $6.02 $7.29
Average True Range (ATR) 0.23 0.34
MACD 0.01 0.03
Stochastic Oscillator 35.70 1.63

Price Performance

Historical Comparison
LGL
XGN

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: